Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Tirzepatide is a once-weekly, dual-incretin peptide it activates both the GIP and the GLP-1 receptor from a single molecule and in published obesity trials it has produced some of the largest average weight reductions of any incretin agent studied to date
Mice were fasted for 16 to 18 h before receiving APAP by intraperitoneal injection (Hu et al
David Sinclair, Ph.D
Local Reactions: Injection site pain or discomfort
By bypassing the digestive tract, IV administration ensures the therapeutic dose reaches target receptors without degradation
Proc Natl Acad Sci U S A (2008) 105:618590.10.1073/pnas.0801447105 21 NencioniLIuvaraAAquilanoKCirioloMRCozzolinoFRotilioGet alInfluenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2
US$ 23.75
US$ 25.56
US$ 26.56
US$ 20.18
US$ 29.32
US$ 24.98
